<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03580512</url>
  </required_header>
  <id_info>
    <org_study_id>POC HIV&amp;STI</org_study_id>
    <nct_id>NCT03580512</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV Into Community-based Clinics for MSM and TGW in Thailand</brief_title>
  <official_title>The Thai Red Cross AIDS Research Centre</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thai Red Cross AIDS Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thai Red Cross AIDS Research Centre</source>
  <brief_summary>
    <textblock>
      This will be a prospective study that will enroll up to 2000 MSM and TG from community-based
      clinics in Bangkok, Chonburi, Chiang Mai, and Songkhla.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible participants will be followed up until the completion of a 12-month period. All
      participants will be followed up every 3 months. An additional follow up visit at month 1
      will be made for participants who PrEP is initiated at entry visit (those who already
      received PrEP prior to the study will not need the additional visit).

      Study Sites

      The study will take place at the following community-based clinics:

        1. SWING DIC, Bangkok, Thailand

        2. RSAT DIC, Bangkok, Thailand

        3. SWING DIC, Chonburi, Thailand

        4. Sisters DIC, Chonburi, Thailand

        5. Mplus DIC, Chiang Mai, Thailand

        6. RSAT DIC, Songkhla, Thailand
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2017</start_date>
  <completion_date type="Anticipated">April 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants who receive same-day diagnosis and treatment of CT/NG in community-based clinics</measure>
    <time_frame>1 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of participants who receive same-day diagnosis of HIV infection in community-based clinics</measure>
    <time_frame>1 years</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Men Who Have Sex With Men and Transgender Women</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>- 800 existing clients who already received PrEP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>800 new clients who present for HIV testing and are HIV-negative. All will be offered PrEP
600 clients who will refuse PrEP
200 clients who will receive PrEP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>- 400 new clients who are HIV-positive or new clients who present for HIV testing and are HIV-positive</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately 2000 MSM and TG
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Thai nationality

          2. Age â‰¥ 18 years old

          3. Men or transgender women who have sex with men

          4. Have at least one of the following risks for HIV acquisition in the past 6 months:

               -  Any unprotected receptive anal sex

               -  More than 5 sexual partners, regardless of condom use and serostatus

               -  History of syphilis, chlamydia or gonorrhea diagnosed or treated

               -  Any stimulant drug use

          5. Have signed the consent form

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nittaya Phanuphak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thai Red Cross AIDS Research Centre (TRCARC)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nittaya Phanuphak, M.D., Ph.D.</last_name>
    <phone>+6681 825 3544</phone>
    <email>nittaya.p@trcarc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reshmie Ramautarsing, M.D.,Ph.D</last_name>
    <phone>662 253 0996</phone>
    <email>reshmie@trcarc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>1.Swing Dic,</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>2.Rsat Dic,</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>5. Mplus DIC,</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>3.Swing Dic</name>
      <address>
        <city>Chon Buri</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>4. Sisters DIC,</name>
      <address>
        <city>Chon Buri</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>6.Rsat Dic,</name>
      <address>
        <city>Songkhla</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 31, 2018</study_first_submitted>
  <study_first_submitted_qc>June 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2018</study_first_posted>
  <last_update_submitted>July 17, 2020</last_update_submitted>
  <last_update_submitted_qc>July 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

